ES2130438T3 - Derivados de imidazo(1,2-a)pirazin-4-ona, su preparacion y los medicamentos que les contienen. - Google Patents

Derivados de imidazo(1,2-a)pirazin-4-ona, su preparacion y los medicamentos que les contienen.

Info

Publication number
ES2130438T3
ES2130438T3 ES94922904T ES94922904T ES2130438T3 ES 2130438 T3 ES2130438 T3 ES 2130438T3 ES 94922904 T ES94922904 T ES 94922904T ES 94922904 T ES94922904 T ES 94922904T ES 2130438 T3 ES2130438 T3 ES 2130438T3
Authority
ES
Spain
Prior art keywords
alk
alkyl
het
phenyl
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94922904T
Other languages
English (en)
Inventor
Jean-Claude Aloup
Francois Audiau
Dominique Damour
Arielle Genevois-Borella
Patrick Jimonet
Serge Mignani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Application granted granted Critical
Publication of ES2130438T3 publication Critical patent/ES2130438T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

COMPUESTOS DE FORMULA (I) EN LA QUE BIEN R REPRESENTA C=R3, C(R4 R5 O CH-R6, R1 Y R2 REPRESENTAN HIDROGENO, HALOGENO,ALQUILO ALCOXI, AMINO ACILAMINO NH_CONH_ AR. C=CH-N(ALK)ALK'', NITRO CIANO, FENILO IMIDAZOLILO O SO3H,R3 REPRESENTA OXIGENO, NOH, NO-ALK,COOX O CHR7, R4 REPRESENTA ALQUILO ALK-HRT O ALK-AR, R5 REPRESENTA ALQUILO, ALK-HET O ALK-AR O BIEN C(R4)R5 REPRESENTA CICLOALQUILO, R6 REPRESENTA HIDROXI,ALQUILO, NR8R9, ALK-OH, ALK-NR8R9, ALK-HET O ALKHET, R7 REPRESENTA HIROXI, ALQUILO, FENILO. ALK-AR, -ALKHET, -NR10R11 O UN HETEROCICLO, R8 Y R9 REPRESENTAN ALQUILO, O BIEN R 8 REPRESENTA HIDROGENO, Y R9 REPRESENTA HIDROGENO OP ALQUILO, -COR1, CSR30 O SO2 R13, R10 Y R11 REPRESENTAN ALQUILO OCICLOALQUILO, R12 REPRESENTA ALQUILO CICLOALQUILO FENILO, -COO-ALK, -NH-HET, BIEN R REPRESENTA UN RADICAL 2-IMIDAZOLILMETILO Y R1 Y R2 REPRESENTAN CADA UNO UN ATOMO DE HIDROGENO -NH-ALK, -NH-AR, NH2 O -NH-HET, BIEN R REPRESENTA UN RADICAL 2-IMIDALILMETILO Y R1 Y R2 REPRESENTAN CADA UNO UN ATOMO DE HIDROGENO. LOS COMPUESTOS DE FORMULAS (I) SON ANTAGONISTAS DEL RECEPTOR DEL ACIDO {AL-AMINO-3-HIDROXI-5-METIL-4-ISOXAZOLOPROPIONICO (AMPA), CONOCIDO TAMBIEN BAJO EL NOMBRE DE RECEPTOR DE QUISCALATO. POR OTRA PARTE, LOS COMPUESTOS DE FORMULA (I) SON ANTAGONISTAS NO COMPETITIVOS DEL RECEPTOR N-METIL-D-ASPARATO (NMDA), Y MAS EN PARTICULAR, SON LIGANDOS PARA LOS LUGARES MODULADORES DE LA GLICINA DEL RECEPTOR NMDA:
ES94922904T 1993-07-16 1994-07-11 Derivados de imidazo(1,2-a)pirazin-4-ona, su preparacion y los medicamentos que les contienen. Expired - Lifetime ES2130438T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9308754A FR2707643B1 (fr) 1993-07-16 1993-07-16 Dérivés d'imidazo[1,2-a]pyrazine-4-one, leur préparation et les médicaments les contenant.

Publications (1)

Publication Number Publication Date
ES2130438T3 true ES2130438T3 (es) 1999-07-01

Family

ID=9449312

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94922904T Expired - Lifetime ES2130438T3 (es) 1993-07-16 1994-07-11 Derivados de imidazo(1,2-a)pirazin-4-ona, su preparacion y los medicamentos que les contienen.

Country Status (18)

Country Link
US (1) US5753657A (es)
EP (1) EP0708774B1 (es)
JP (1) JPH09500873A (es)
AT (1) ATE177746T1 (es)
AU (1) AU681688B2 (es)
CA (1) CA2167169A1 (es)
DE (1) DE69417235T2 (es)
DK (1) DK0708774T3 (es)
ES (1) ES2130438T3 (es)
FI (1) FI960160A (es)
FR (1) FR2707643B1 (es)
GR (1) GR3029713T3 (es)
HU (1) HUT74678A (es)
IL (1) IL110329A0 (es)
NO (1) NO955192L (es)
PL (1) PL312571A1 (es)
WO (1) WO1995002601A1 (es)
ZA (1) ZA945045B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2717813B1 (fr) * 1994-03-28 1996-05-10 Rhone Poulenc Rorer Sa Dérivés d'imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, leur préparation et les médicaments les contenant .
FR2717805B1 (fr) * 1994-03-28 1996-05-10 Rhone Poulenc Rorer Sa Dérivés de 5H-indeno[1,2-b]pyrazine-2,3-dione, leur préparation et les médicaments les contenant .
FR2717812B1 (fr) * 1994-03-28 1996-05-10 Rhone Poulenc Rorer Sa Indeno[1,2-e]pyrazine-4-ones, leur préparation et les médicaments les contenant.
FR2726275B1 (fr) * 1994-11-02 1996-12-06 Rhone Poulenc Rorer Sa Spiro heterocycle-imidazo(1,2-a)indeno(1,2-e)pyrazine)-4'- ones, leur preparation et les medicaments les contenants
FR2738821B1 (fr) * 1995-09-15 1997-11-21 Rhone Poulenc Rorer Sa Indeno[1,2-e]pyrazin-4-ones, leur preparation et les medicaments les contenant
US7375136B2 (en) * 2001-03-08 2008-05-20 Emory University pH-dependent NMDA receptor antagonists
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
NZ576606A (en) * 2006-10-30 2012-04-27 Hybrigenics Sa Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
WO2008055945A1 (en) 2006-11-09 2008-05-15 Probiodrug Ag 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
WO2008065141A1 (en) 2006-11-30 2008-06-05 Probiodrug Ag Novel inhibitors of glutaminyl cyclase
ZA200905537B (en) 2007-03-01 2010-10-27 Probiodrug Ag New use of glutaminyl cyclase inhibitors
JP5667440B2 (ja) 2007-04-18 2015-02-12 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体
US8420680B2 (en) * 2007-06-29 2013-04-16 Emory University NMDA receptor antagonists for neuroprotection
MX2012002993A (es) 2009-09-11 2012-04-19 Probiodrug Ag Derivados heterociclicos como inhibidores de ciclasa glutaminilo.
JP6026284B2 (ja) 2010-03-03 2016-11-16 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤
MX2012010470A (es) 2010-03-10 2012-10-09 Probiodrug Ag Inhibidores heterociclicos d ciclasa de glutaminilo (qc, ec .3 2. 5).
US8541596B2 (en) 2010-04-21 2013-09-24 Probiodrug Ag Inhibitors
WO2012123563A1 (en) 2011-03-16 2012-09-20 Probiodrug Ag Benz imidazole derivatives as inhibitors of glutaminyl cyclase
EP3461819B1 (en) 2017-09-29 2020-05-27 Probiodrug AG Inhibitors of glutaminyl cyclase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9049391A (en) * 1990-12-20 1992-07-22 Warner-Lambert Company 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity
US5196421A (en) 1991-06-05 1993-03-23 Eli Lilly And Company Excitatory amino acid receptor antagonists in methods for the use thereof
US5153196A (en) * 1991-06-05 1992-10-06 Eli Lilly And Company Excitatory amino acid receptor antagonists and methods for the use thereof
FR2696466B1 (fr) * 1992-10-02 1994-11-25 Rhone Poulenc Rorer Sa Dérivés de 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, leur préparation et les médicaments les contenant.

Also Published As

Publication number Publication date
FR2707643B1 (fr) 1995-08-11
FR2707643A1 (fr) 1995-01-20
EP0708774A1 (fr) 1996-05-01
JPH09500873A (ja) 1997-01-28
PL312571A1 (en) 1996-04-29
EP0708774B1 (fr) 1999-03-17
US5753657A (en) 1998-05-19
DE69417235D1 (de) 1999-04-22
AU681688B2 (en) 1997-09-04
CA2167169A1 (fr) 1995-01-26
DK0708774T3 (da) 1999-10-11
ZA945045B (en) 1995-02-22
HU9503955D0 (en) 1996-03-28
IL110329A0 (en) 1994-10-21
FI960160A0 (fi) 1996-01-12
NO955192D0 (no) 1995-12-20
FI960160A (fi) 1996-01-12
WO1995002601A1 (fr) 1995-01-26
NO955192L (no) 1995-12-20
HUT74678A (en) 1997-01-28
GR3029713T3 (en) 1999-06-30
DE69417235T2 (de) 1999-07-08
ATE177746T1 (de) 1999-04-15
AU7265294A (en) 1995-02-13

Similar Documents

Publication Publication Date Title
ES2130438T3 (es) Derivados de imidazo(1,2-a)pirazin-4-ona, su preparacion y los medicamentos que les contienen.
ES8703142A1 (es) Proceso para preparar un derivado del bencimidazol.
ES2134460T3 (es) Derivados de 5h-indeno(1,2-b)-pirazina-2,3-diona, su preparacion y los medicamentos que les contienen.
GR3022498T3 (en) Imidazo[1,2-a]pyrazin-4-one derivatives for use as ampa and nmda receptor antagonists
NO165072C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-vinyl-og 3-ethynyl-8-carbolinderivater.
FI964463A (fi) Bisykliset amidiinijohdannaiset typpioksidinsyntetaasin inhibiittoreina
ES2116467T3 (es) Derivados de 5h,10h-imidazo(1,2-a)indeno(1,2-e)pirazina-4-ona, su preparacion y los medicamentos que les contienen.
ES2134459T3 (es) Indeno(1,2-e)pirazina-4-onas, su preparacion y los medicamentos que les contienen.
ES2158099T3 (es) Derivados de imidazo(1,2-a)indeno(1,2-e)pirazina-4-ona y composiciones farmaceuticas que los contienen.
DE69431471D1 (de) Amide derivate als 5-ht1a liganden
ES479110A1 (es) Procedimiento para preparar derivados de benzamidina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 708774

Country of ref document: ES